Partner Fund Management L.P. 13D and 13G filings for Caribou Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:03 pm Sale |
2024-09-30 | 13G | Caribou Biosciences, Inc. CRBU |
Partner Fund Management L.P. | 4,306,671 4.800% |
-2,174,093 (-33.55%) |
Filing |
| 2024-02-14 4:06 pm Purchase |
2023-12-31 | 13G | Caribou Biosciences, Inc. CRBU |
Partner Fund Management L.P. | 6,480,764 7.300% |
2,020,981 (+45.32%) |
Filing |
| 2023-02-14 4:06 pm Purchase |
2022-12-31 | 13G | Caribou Biosciences, Inc. CRBU |
Partner Fund Management L.P. | 4,459,783 7.300% |
367,474 (+8.98%) |
Filing |
| 2022-02-14 12:35 pm Unchanged |
2021-12-31 | 13G | Caribou Biosciences, Inc. CRBU |
Partner Fund Management L.P. | 4,092,309 6.800% |
0 (Unchanged) |
Filing |
| 2021-08-06 5:04 pm Purchase |
2021-07-27 | 13G | Caribou Biosciences, Inc. CRBU |
Partner Fund Management L.P. | 4,092,309 7.200% |
4,092,309 (New Position) |
Filing |